Pharmacist-led pre-infusion screening using absolute lymphocyte count and neutrophil-to-lymphocyte ratio before immune checkpoint inhibitor therapy: A practice proposal
{{output}}
BackgroundImmune checkpoint inhibitor (ICI) eligibility is primarily guided by tumor-centric biomarkers that do not fully account for the host's systemic immune competence. Emerging evidence suggests that readily available hematologic indices absolute lymphoc... ...
